The MBS landscape is undergoing a paradigm shift. Optimal obesity management is evolving beyond rigid anatomical algorithms towards precision medicine, driven by the synergistic integration of dual glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonists, procedure personalisation based on metabolic phenotyping and robust lifelong surveillance registries tailored to regional demographics.
Building similarity graph...
Analyzing shared references across papers
Loading...
Vidit Dholakia
Das S
Samiran Nundy
Journal of Minimal Access Surgery
Sir Ganga Ram Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Dholakia et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69df2c62e4eeef8a2a6b17e1 — DOI: https://doi.org/10.4103/jmas.jmas_551_25